Twelve likely modifiable threat/protecting elements for dementia happen to be recently determined, as listed in Desk 1Together, these aspects account for approximately 40% of dementia risk worldwide, that may theoretically be prevented. Aducanumab could be the first of many illness‐modifying prescription drugs coming for the clinic, and has creat